ICUI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ICU Medical Inc (ICUI) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows some positive signs, such as improving operational efficiency and a better outlook for 2026, the recent financial performance and lack of strong trading signals suggest holding off for now. The stock's technical indicators are neutral, and there are no significant catalysts to suggest immediate upside potential.
The MACD is positive at 0.248 but contracting, indicating weakening momentum. RSI is neutral at 47.865, suggesting no overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading near its pivot point (150.303) with limited upside to the next resistance level (R1: 157.649).
Analysts have raised price targets to $178-$180, citing improved operational efficiency and achievable 2026 guidance. Gross margin increased by 4.05% YoY, and the company expects significant net income growth in 2026.
Revenue declined by 14% YoY in Q4 2025, and net income dropped by 33.97% YoY. EPS also fell by 34.02% YoY. The overall market sentiment is neutral, with no significant insider or hedge fund activity.
In Q4 2025, revenue dropped to $540.7 million (-14.15% YoY), net income fell to -$15.73 million (-33.97% YoY), and EPS declined to -0.64 (-34.02% YoY). However, gross margin improved to 37.54% (+4.05% YoY). For the full year 2025, the company achieved a net income of $0.73 million, a significant improvement from a net loss the previous year.
Analysts from KeyBanc and Piper Sandler have raised price targets to $180 and $178, respectively, maintaining Overweight ratings. They cite improving business operations and achievable 2026 guidance as key reasons for their optimism.
